Cytokine Response Modifier A (CrmA) Inhibits Ceramide Formation in Response to Tumor Necrosis Factor (TNF)-α: CrmA and Bcl-2 Target Distinct Components in the Apoptotic Pathway
J Exp Med (1997) 185 (3): 481–490.
Currently there are no citedby results. Try again later.
